Adi Zamir

Adi Zamir currently serves as the Chief Growth Officer at Hy Laboratories Ltd since June 2025. Previously held roles include Business Development Manager at Roche Global Diagnostics, where significant contributions were made in global strategy and partnerships, and consultant for UPS focusing on digital transformation in logistics. As the Founder and CEO of Pink of View, Adi Zamir developed AI-driven risk assessment tools for breast cancer, and also spearheaded Emerald Medical Applications as CEO, focusing on skin cancer detection technologies. Earlier experience encompasses various leadership roles in organizational training and consulting at Ness Technologies and other companies, along with significant contributions to educational and digital project management at the National Library of Israel. Adi Zamir is pursuing a PhD in Health Administration at Bar-Ilan University, having previously completed an EMBA, an MA in Law, and an MA in Education, along with a Bachelor's degree in Science Education.